Moderna

$128.40
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$17.85 (+16.35%) Today
+$1.37 (+1.08%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell Moderna and other stocks, options, and ETFs commission-free!

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA. The listed name for MRNA is Moderna, Inc. Common Stock.

CEO
Stéphane Bancel
Employees
830
Headquarters
Cambridge, Massachusetts
Founded
2010
Market Cap
50.27B
Price-Earnings Ratio
Dividend Yield
Average Volume
26.25M
High Today
$130.06
Low Today
$114.86
Open Price
$115.12
Volume
43.44M
52 Week High
$130.06
52 Week Low
$17.68

Collections

Digestible Financial News

Jack Kramer & Nick Martell

Managing Editors of News & Snacks at Robinhood Financial LLC

MRNA News

CNBC7h

UK secures 2 million more doses of Moderna's Covid vaccine

Researchers work in a lab run by Moderna Inc, who said November 16, 2020 that its experimental vaccine was 94.5% effective in preventing COVID-19 based on inter
MarketWatchNov 27

Moderna Inc. stock outperforms competitors on strong trading day

Shares of Moderna Inc. MRNA, +16.34% climbed 16.35% to $127.03 Friday, on what proved to be an all-around favorable trading session for the stock market, with t
BenzingaNov 24

Reinventing Vaccines To Save Lives And The Economy

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) were the first to deliver good news regarding the efficiency of their coronavirus vaccine candidate. Mode

MRNA Earnings

-$0.59
-$0.39
-$0.20
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 24, Pre-Market

You May Also Like

More MRNA News

ReutersNov 24

Sweden's Recipharm signs deal to package Moderna's COVID-19 vaccine

FILE PHOTO: Coronavirus: On November 16, 2020, US biotech company Moderna announced a vaccine against COVID-19 that is 94.5% effective. Montreal, November 16, 2
CNBCNov 23

Dow rises more than 100 points to start the week amid more positive vaccine news

Stocks rose on Monday after AstraZeneca and the University of Oxford said their coronavirus vaccine was up to 90% effective, becoming the third inoculation this